Please wait while the formulary information is being retrieved.
STRONTIUM-89 CHLORIDE (strontium-89 chloride)
- Pain due to osteoblastic bone metastasis
1 mCi/mL intravenous solution
- Dosage information is not available
1 mCi/mL intravenous solution
- Dosage information is not available
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Pregnancy
Contraindicated
- Leukopenia
- Secondary malignant neoplasm of bone marrow
- Severe bone marrow depression
- Thrombocytopenic disorder
Severe
Moderate
- None
STRONTIUM-89 CHLORIDE (strontium-89 chloride)
- Pain due to osteoblastic bone metastasis
- Bone marrow depression
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Chills
- Fever
- Flushing
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Strontium-89 chloride
No established safety and efficacy in pediatrics.
- 1 Day – 18 Years
- No established safety and efficacy in pediatrics.
Strontium Chloride-89
- Severity Level:
1
- Additional Notes:
Contraindicated
Strontium Chloride-89
Excretion likely per mfr, not recommended
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Excretion likely per mfr, not recommended |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Pain due to osteoblastic bone metastasis | |
C79.51 | Secondary malignant neoplasm of bone |
G89.3 | Neoplasm related pain (acute) (chronic) |
0-9 | A-Z |
---|---|
C79.51 | Secondary malignant neoplasm of bone |
G89.3 | Neoplasm related pain (acute) (chronic) |
Formulary Reference Tool